CA
PFE icon

CV Advisors’s Pfizer PFE Stock Holding History

CV Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
+26,200
New +$685K 0.12% 73

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CV Advisors's PFE Position: Q2 2026 in Review

CV Advisors opened a new position in Pfizer (PFE) in Q2 2026: 26,200 shares worth $631K. The stake represents 0.12% of the portfolio and ranks #73 among its holdings.

669 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • CV Advisors held 26,200 shares of Pfizer worth $631K as of Q2 2026.
  • Pfizer was a new CV Advisors position in Q2 2026.
  • Pfizer made up 0.12% of CV Advisors's portfolio in Q2 2026, its #73 holding.
  • 669 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CV Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.